• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Effects of various antiplatelet drugs and defibrinating agent on experimental glomerulonephritis in rats.

作者信息

Ogawa S, Naruse T

出版信息

J Lab Clin Med. 1982 Mar;99(3):428-41.

PMID:6460069
Abstract

Two types of experimental GN induced by immunological procedures. Heymann-type AIC-GN and NTN, were treated with anticoagulant agents. Dipyridamole, aspirin, ticlopidine or batroxobin was administered either to rats with AIC-GN for 14 to 28 days or to NTN rats 2 days prior to injection with NTS and 14 to 21 days thereafter. A significant decrease in the amount of urinary protein was observed only in rats treated with 12.5 to 50.0 mg/kg dipyridamole daily, whereas no significant decrease in proteinuria was observed in either AIC-GN or NTN rats treated with the other agents. Histopathologically, no improvement in the light and electron microscopic findings was noted in AIC-GN rats treated with these agents, even with dipyridamole. On the other hand, in NTN rats, light and electron microscopic study of the kidneys from rats sacrificed 30 to 60 min after NTS injection revealed that platelet aggregation and inflammatory changes in the glomeruli were remarkable reduced in rats pretreated with 56.4 mg/kg aspirin or 50.0 mg/tg triclopidine daily, but no difference in the renal lesions between rats treated with aspirin or triclopidine and control animals were observed 2 weeks after NTS injection. No histological improvement was observed in rats pretreated with dipyridamole. It would be reasonable to conclude from these results that the favorable effect of dipyridamole on proteinuria is not related to its antiplatelet activity and that platelet aggregation is not essential to the development of renal lesions in rat AIC-GN and NTN. (J Lab Clin Med 99:428, 1982.)

摘要

相似文献

1
Effects of various antiplatelet drugs and defibrinating agent on experimental glomerulonephritis in rats.
J Lab Clin Med. 1982 Mar;99(3):428-41.
2
Effect of the antiplatelet agents ticlopidine and dipyridamole on experimental immune complex glomerulonephritis in rats.抗血小板药物噻氯匹定和双嘧达莫对大鼠实验性免疫复合物性肾小球肾炎的影响。
Nephron. 1986;43(1):56-61. doi: 10.1159/000183719.
3
Effect of the antiplatelet agents ticlopidine and dipyridamole on nephrotoxic serum nephritis in rats.
Nephron. 1987;45(4):306-10. doi: 10.1159/000184169.
4
Antiplatelet aggregators inhibit development of stress ulcers in Sprague-Dawley rats.抗血小板聚集剂可抑制斯普拉格-道利大鼠应激性溃疡的形成。
Eur Surg Res. 1985;17(1):44-52. doi: 10.1159/000128446.
5
Therapeutic effect of a newly developed antioxidative agent (OPC-15161) on experimental immune complex nephritis.一种新开发的抗氧化剂(OPC-15161)对实验性免疫复合物肾炎的治疗作用。
Nephron. 1997;76(3):315-22. doi: 10.1159/000190198.
6
Antithrombotic effects of ticlopidine, acetylsalicyclic acid and dipyridamole in vascular shunt model in rats.噻氯匹定、乙酰水杨酸和双嘧达莫在大鼠血管分流模型中的抗血栓形成作用。
Thromb Res. 1980 Mar 1;17(5):663-71. doi: 10.1016/0049-3848(80)90369-2.
7
Antithrombotic effect of ticlopidine in a platelet-independent model of venous thrombosis.
Thromb Res. 1985 Jan 15;37(2):279-85. doi: 10.1016/0049-3848(85)90016-7.
8
Platelets mediate neutrophil-dependent immune complex nephritis in the rat.血小板介导大鼠中性粒细胞依赖性免疫复合物肾炎。
J Clin Invest. 1988 Oct;82(4):1225-35. doi: 10.1172/JCI113720.
9
Adenosine diphosphate (ADP)-induced alpha-granules release from platelets of native whole blood is reduced by ticlopidine but not by aspirin or dipyridamole.噻氯匹定可减少由二磷酸腺苷(ADP)诱导的天然全血血小板α-颗粒释放,但阿司匹林或双嘧达莫则无此作用。
Thromb Haemost. 1986 Oct 21;56(2):147-50.
10
Comparison of the inhibitory effects of aspirin and ticlopidine on platelet aggregation and Ca2+ mobilization in rat platelets.阿司匹林和噻氯匹定对大鼠血小板聚集及Ca2+动员抑制作用的比较。
Res Commun Chem Pathol Pharmacol. 1986 Nov;54(2):275-8.

引用本文的文献

1
Ticlopidine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in platelet-dependent disease states.噻氯匹定。对其药效学、药代动力学特性以及在血小板相关疾病状态下的治疗效果的综述。
Drugs. 1987 Aug;34(2):222-62. doi: 10.2165/00003495-198734020-00003.
2
Absence of effect of dipyridamole on renal and platelet function in diabetes mellitus.双嘧达莫对糖尿病患者肾脏及血小板功能无影响。
Arch Dis Child. 1990 Jan;65(1):93-8. doi: 10.1136/adc.65.1.93.
3
Ticlopidine. An updated review of its pharmacology and therapeutic use in platelet-dependent disorders.
噻氯匹定。其药理学及在血小板相关疾病治疗应用的最新综述。
Drugs. 1990 Aug;40(2):238-59. doi: 10.2165/00003495-199040020-00006.
4
FK506, a novel immunosuppressive agent, induces antigen-specific immunotolerance in active Heymann's nephritis and in the autologous phase of Masugi nephritis.新型免疫抑制剂FK506可在活动性海曼肾炎及肾毒血清性肾炎自身期诱导抗原特异性免疫耐受。
Clin Exp Immunol. 1990 Dec;82(3):450-5. doi: 10.1111/j.1365-2249.1990.tb05470.x.